The schizophrenia-associated gene Dtnbp1 is expressed with a daily rhythm in the brain's master clock (SCN) and colocalizes with VIP and AVP neuropeptide neurons, though its mutation did not alter neuropeptide expression or synaptic architecture.
Colocalizes with VIP and AVPThe schizophrenia risk gene Dtnbp1 is expressed in the same master clock neurons that produce the circadian neuropeptides VIP and AVP, with daily rhythmic expression
What the researchers found
DTNBP1 protein was expressed throughout the SCN, with stronger expression in the dorsal region. Critically, DTNBP1 colocalized with neurons expressing both AVP (arginine vasopressin peptide) and VIP (vasoactive intestinal peptide) — two key neuropeptides that coordinate circadian rhythms across the body. Fluorescent in situ hybridization revealed time-dependent (daily rhythmic) variation of Dtnbp1 transcript expression in these neuropeptide cell bodies.
However, in Sandy (Sdy) mice carrying a loss-of-function Dtnbp1 mutation, there was no significant effect on AVP or VIP expression in the SCN. Transmission electron microscopy showed no effect on synaptic morphology or secretory vesicles. The circadian locomotor activity disruption previously observed in these mice therefore likely involves mechanisms beyond neuropeptide expression changes or gross synaptic architecture alterations.
Why it matters
Circadian disruption is one of the most consistent features of schizophrenia, affecting sleep, cognition, and medication efficacy. Understanding how schizophrenia risk genes interact with the brain's clock system — and specifically with the neuropeptides that run it — could reveal new therapeutic targets. While this study found no simple disruption of VIP/AVP levels, the rhythmic expression of Dtnbp1 in these neuropeptide neurons suggests more subtle functional roles worth investigating.
How the study worked
The study used immunohistochemistry to map DTNBP1 protein expression in the SCN and determine colocalization with AVP and VIP neuropeptide neurons. Fluorescent in situ hybridization (FISH) assessed temporal expression patterns of Dtnbp1 mRNA. Sandy (Sdy) mutant mice (lacking functional DTNBP1) were compared with wild-type controls for neuropeptide expression levels and synaptic ultrastructure using transmission electron microscopy.
What this study cannot tell us
The study used a single mouse model (Sandy mice) which may not fully recapitulate human schizophrenia-associated Dtnbp1 dysfunction. The null result on neuropeptide expression doesn't rule out subtler functional effects on peptide release dynamics, receptor signaling, or temporal patterning. The SCN is only one brain region where Dtnbp1 may influence circadian behavior. Sample sizes for the mouse experiments were not specified in the abstract.
How to read the evidence
This is a preclinical basic science study in mice using multiple validated techniques (immunohistochemistry, FISH, electron microscopy). It provides solid anatomical and expression data but includes a null result on the primary hypothesis (neuropeptide disruption). The findings are descriptive and require functional follow-up.
When this study was published
Published in 2026, this is very recent research at the frontier of understanding how genetic risk factors for schizophrenia interact with the brain's circadian neuropeptide systems.
The bigger picture
This study sits at the intersection of psychiatric genetics, circadian biology, and neuropeptide neuroscience. VIP and AVP are master regulators of the body's internal clock — VIP synchronizes individual clock cells in the SCN, while AVP serves as a major output signal. Finding a schizophrenia risk gene expressed in these critical neuropeptide neurons strengthens the link between circadian disruption and psychotic disorders, even if the specific mechanism remains to be elucidated.
Questions still open
- Does Dtnbp1 mutation affect the temporal pattern or release dynamics of VIP and AVP even if steady-state levels remain unchanged?
- Could Dtnbp1 influence circadian rhythms through effects on neuropeptide signaling pathways downstream of VIP and AVP receptors?
- Do schizophrenia patients with Dtnbp1 variants show more severe circadian disruption than those without?
Common questions
What are VIP and AVP and why are they important for the body clock?
Why do many schizophrenia patients have sleep problems?
Read the original research
Characterization of the expression and function of schizophrenia risk gene Dtnbp1 in the suprachiasmatic nucleus.
Neuroscience, 595, 250-261
Citation
Maloney, Genavieve Elizabeth; Cloutier, Marie-Ève; Provost, Micah Joseph; Srivastava, Lalit K; Cermakian, Nicolas. (2026). Characterization of the expression and function of schizophrenia risk gene Dtnbp1 in the suprachiasmatic nucleus.. Neuroscience, 595, 250-261. https://doi.org/10.1016/j.neuroscience.2025.12.029